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Astrocytes have a central role in brain development and function, and so have gained
increasing attention over the past two decades. Consequently, our knowledge about
their origin, differentiation and function has increased significantly, with new research
showing that astrocytes cultured alone or co-cultured with neurons have the potential
to improve our understanding of various central nervous system diseases, such as
amyotrophic lateral sclerosis, Alzheimer’s disease, or Alexander disease. The generation
of astrocytes derived from pluripotent stem cells (PSCs) opens up a new area for
studying neurologic diseases in vitro; these models could be exploited to identify
and validate potential drugs by detecting adverse effects in the early stages of drug
development. However, as it is now known that a range of astrocyte populations exist
in the brain, it will be important in vitro to develop standardized protocols for the in vitro
generation of astrocyte subsets with defined maturity status and phenotypic properties.
This will then open new possibilities for co-cultures with neurons and the generation
of neural organoids for research purposes. The aim of this review article is to compare
and summarize the currently available protocols and their strategies to generate human
astrocytes from PSCs. Furthermore, we discuss the potential role of human-induced
PSCs derived astrocytes in disease modeling.
Keywords: astrocyte, glial, central nervous system (CNS), Alzheimer disease (AD), brain pathology, microglia,
CNTF, brain damage and repair
INTRODUCTION
Central nervous system neurons are never alone; they are often connected with astrocytes along
with other cell types to form structural and functional networks. Astrocytes are the most abundant
cell types in the CNS (Azevedo et al., 2009) with a remarkable heterogeneity both in morphology
and function. In the past, astrocytes were believed to act as “passive support cells” for electrically
Abbreviations: Aβ, amyloid-beta; AD, Alzheimer’s disease; ALS, amyotrophic lateral sclerosis; ApoE, apolipoprotein
E; AQP-4, aquaporin-4; AxD, Alexander disease; BBB, blood–brain barrier; BMP, bone morphogen protein; CT-1,
Cardiotrophin-1; CNS, central nervous system; CNTF, ciliary neurotrophic factor; DS, down syndrome; EAAT1 and EAAT2,
excitatory amino acid transporter1/2; EBs, embryoid body; EOAD, early onset Alzheimer’s disease; FGF-2 or bFGF, fibroblast
growth factors; GFAP, glial fibrillary acid protein; GDH, glutamate dehydrogenase; GLT-1, glutamate transporter; GS,
glutamine synthase; HE, hepatic encephalopathy; hESCs, human embryonic stem cells; iPSCs, induced pluripotent stem
cells; iSVZ, inner SVZ; IL-6, interleukin-6; IPC, intermediate progenitor cells; LOAD, late onset-AD; LIF, leukemia inhibitory
factor; MCTs, monocarboxylate transporters; MNs, motor neurons; NMO, neuromyelitis optica; oSVZ, outer SVZ; PSCs,
pluripotent stem cells; RGs, radial glial; RGC, retinal ganglion cells; RA, retinoic acid; RF, rosenthal fibers; SPs, senile plaques;
SHH, sonic hedgehog; SVZ, subventricular zone; SOD-1, superoxide dismutase; TCA, tricarboxylic acid cycle.
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active neurons and to be primarily responsible for cellular
homeostasis of the CNS, but current research shows their
active participation in many other processes such as the
formation of neural networks, recycling of neurotransmitters,
and detoxification (Nedergaard et al., 2003; Krencik and Ullian,
2013). Many other functions are also beginning to emerge as
the research on astrocytes continues, and our understanding of
their disease-relevant cellular functions in several diseases has
already been revised. Here, we review the role of astrocytes,
compare their in vivo and in vitro differentiation, and discuss the
pathomechanisms of certain diseases in which they are involved.
THE ROLE OF ASTROCYTES IN THE CNS
Astrocytes play a direct and critical role in the developing
CNS in maintaining an optimal environment for the normal
development and function of neurons. Some examples of
astrocytic functions include energy supply, the formation
of the BBB, and removal of toxins and debris (described
below). Impairments in these functions, as well as physiological
fluctuation in glutamate/K+ levels, can trigger or exacerbate
neuronal dysfunction (Zhang et al., 2016). Based on their
important and physiological role, it is not at all surprising that
changes in astrocytes can directly affect the behavior of rodents
(Franke and Kittner, 2001).
Energy Supplies for Neurons
One of the oldest known functions of astrocytes is to supply
energy in the form of lactate to neurons. Glucose is mainly stored
as glycogen in astrocytes, where it is metabolized to pyruvate and
lactate and then transported via MCTs across the cell membrane.
The transported lactate is then utilized by neighboring neurons
and metabolized (Magistretti et al., 1999). Apart from glucose
metabolism, astrocytes are also involved in glutamate uptake via
two pathways. The first pathway involves the direct conversion of
glutamate to α-ketoglutarate through NAD-dependent oxidative
deamination catalyzed by GDH, and the second pathway is
an ATP-requiring reaction in which ammonium is catalyzed
by GS to yield glutamine. This glutamate-glutamine shuttle
protects against the toxic effects caused by extracellular glutamate
(Sonnewald et al., 1997).
Maintenance of the Cellular
Homeostasis of the Brain
One essential function of astrocytes is to maintain brain
homeostasis through multiple dynamic equilibrium adjustments,
including water balance, ion distribution, glutamate buffering,
and recycling (Wang and Qin, 2010; Coulter and Eid, 2012).
High levels of synaptic glutamate can cause over-activation of
neurons which may lead to excitotoxicity; thus rapid removal
of extracellular glutamate from the synaptic cleft is essential for
neuronal survival (Dong et al., 2009). This is accomplished by
Na+ dependent transporters on astrocytes, EAAT1 and EAAT2,
respectively.
Apart from glutamate clearance, astrocytes can control
cerebral glutamate levels (Stobart and Anderson, 2013).
Glutamate that is taken up by the astrocytes is converted to
glutamine by GS, then later passed back to the synaptic terminal
where it is converted back to glutamate (Danbolt, 2001; Parpura
and Verkhratsky, 2012). There is increasing evidence that
the uptake of glutamate also induces glycolysis in astrocytes,
resulting in the production and secretion of lactate for the
neighboring neurons (Ricci et al., 2009; Bélanger et al., 2011;
Stobart and Anderson, 2013). This mechanism, the astrocyte to
neuron lactate shuttle, regulates lactate delivery in an activity-
dependent manner (Pellerin et al., 1998; Stobart and Anderson,
2013).
Formation and Maintenance of the
Blood–Brain Barrier
Together with endothelial cells and pericytes of the brain
microvessels, astrocytes form the BBB, a physical diffusion barrier
which restricts the exchange of most molecules between blood
and brain (Abbott et al., 2006; Macvicar and Newman, 2015).
Astrocytes are also involved in regulating cerebral blood flow
by a K+ siphoning mechanism, releasing K+ onto blood vessels
from their end-feet in response to neuronal activity (Paulson
and Newman, 1987). It has been suggested that the release of
prostaglandins from astrocytes results in increased Ca2+ that
evokes vessel dilation (Zonta et al., 2003). Likewise, they are also
involved in regulating BBB permeability from the bloodstream
to brain parenchyma by the activation of tight junction proteins
through NF-κB (Brown et al., 2003; Abbott et al., 2006).
BBB defects are involved in many neuroinflammatory and
neurodegenerative diseases, including multiple sclerosis, where
the specialized brain endothelial cells which comprise the BBB
are diminished, causing a loss of protective function during the
progressive phase of disease (Weiss et al., 2009).
Synapse Formation, Maintenance, and
Pruning
There is now abundant evidence to support the notion that
astrocytes are actively involved in the formation and refinement
of neural networks (Oberheim et al., 2006; Araque and Navarrete,
2010). During development, billions of neurons connect to form
functional networks via synapses, with the control of synapse
development by astrocytes highly conserved across species.
A distinctive attribute of astrocytes in synapse formation is to
increase the number of synaptic structures (dendritic spine)
within the neural circuits (Ullian et al., 2001; Slezak and Pfrieger,
2003; Stevens et al., 2007; Stipursky et al., 2011; Clarke and Barres,
2013). The first evidence for astrocytes being involved in synapse
formation came from the rodent RGC study, which showed that
culture with astrocytes resulted in a 10-fold increase in excitatory
synapse and synaptic functionality (Meyer-Franke et al., 1995).
Later, in vitro studies confirmed that astrocytes can also instruct
synapse formation for human neurons (Diniz et al., 2012).
Astrocytes are also involved in the refinement of the neural
network by synaptic pruning - the elimination of extra synapses
to increase the precision and efficiency of neural circuits (Clarke
and Barres, 2013). The mouse retinogeniculate system, an
excellent model system for studying synapse refinement and
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elimination (Hong and Chen, 2011), has been used to show
that signals released from astrocytes in the postnatal brain
induced the expression of the complement component C1q
that executes synapse elimination by astrocytes via phagocytosis
(Stevens et al., 2007). Notably, astrocytes employ this mechanism
throughout the nervous system (e.g., in the uninjured brain or in
response to glioma or trauma). However, further work is required
to investigate the phagocytic pathway of astrocytes in human
models.
Communication between Astrocytes and
Neurons
Studying the direct communication between astrocytes and
neurons is a rapidly expanding field of neuroscience. The term
“tripartite synapse,” was proposed 20 years ago to describe
synaptic physiology involving astrocytes, in addition to pre-
and post-synaptic neurons. In this context, astrocytes release
neuroactive molecules (such as glutamate, ATP, nitric oxide,
prostaglandins, and D-serine) in the presence of elevated Ca2+,
which in turn influence neuronal excitability (Araque et al., 1999;
Perea et al., 2009; Eroglu and Barres, 2010).
The concept of “gliotransmission,” which was first
hypothesized in the 1980s, involves the active vesicular release
of neurotransmitters and glutamate by astrocytes (Halassa et al.,
2007). In other words, the GPCR-mediated Ca2+ variations
in astrocytes can trigger the release of glutamate, D-serine,
and ATP. So far, various mechanisms have been proposed for
gliotransmission, including Ca2+-regulated vesicular exocytosis
(Agulhon et al., 2012) and non-vesicular release. Additionally,
Santello et al. (2011) found that cytokines are required for
functional glutamatergic gliotransmission. While the importance
of gliotransmission is supported by findings that dysfunction
of astrocytic proteins involved in transmitter release can cause
severe brain disorders (Rossi et al., 2011), there are still several
features of gliotransmission that are controversial and require
further clarification (Hamilton and Attwell, 2010; Sahlender
et al., 2014; Sloan and Barres, 2014).
CLASSIFICATION OF ASTROCYTES: A
HETEROGENIC GROUP OF CELLS
Astrocytes can exist in two distinct developmental stages: a
highly proliferative state, which occurs within the developing
brain in the first weeks after birth, or a mature state/post-
mitotic astrocytes (Ge et al., 2012). The peculiar morphology of
mature mammalian astrocytes was first observed in mice by Otto
Deiters in 1865 using chromic acid and carmine red staining
(Deiters and Guillery, 2013). A detailed morphological study
achieved by Camillo Golgi and Ramón y Cajal, who developed
the black staining reaction and produced drawings of stained
glial cells in 1872, revealed the distinct morphological pattern
of the protoplasmic and fibrous astrocytes. These cells were first
called “astrocyte” in 1893 by Mihály Lenhossék, a Hungarian
anatomist and histologist, who stated that astrocytes are a mixed
population of cells and not a single cell type. Based on our
current understanding, there are a range of astrocyte subtypes
differing in their cellular morphologies and anatomical locations
in the brain (summarized in Table 1). Astrocyte morphologies
vary considerably amongst cortical regions and display distinct
biochemical/biophysical properties throughout discrete regions
of the cortex (Emsley and Macklis, 2006; Regan et al., 2007). Due
to their diversity, developing a full characterization of astrocytes
is challenging.
IDENTIFICATION OF ASTROCYTES
The identification of astrocytes in vivo is usually based on staining
of the cells for their content of GFAP. This microfilament protein
shows a high specificity for astrocytes in brain tissue. As it is
expressed in virtually all reactive astrocytes, it is particularly
useful for identification of astrocytes in diseased brain. On the
basis of such studies, it is known that the cells can change their
morphology if they are activated or form scars (Anderson et al.,
2016), but in general they display a typically stellate morphology.
Rodent studies have shown that GFAP expression is not essential
for astrocytes, and that subpopulations of resting astrocytes do
not express the microfilament protein (Kuegler et al., 2012).
As also subpopulations of resting human astrocytes may not
stain for GFAP, their morphology is yet little characterized, and
new markers are urgently needed (Zhang et al., 2016). The
capacity of astrocytes to change shape is also obvious in vitro. If
pure populations are cultured under standard conditions, cells
are found to be flat and of a roughly polygonal or feathery
shape, but if astrocytes are co-cultured with neurons, they can
assume a stellate shape. Whilst most of the studies on astrocyte
cultures were based on the rodent, Guillemin et al. (1997)
isolated and characterized astrocytes from primate brain to study
the differences between human and non-human primate CNS.
Later it was confirmed that in vivo primate astrocytes have a
stellate morphology, and express high levels of GFAP (Oberheim
et al., 2009). Further, it was found that transient acidification
of the culture media resulted in stellation of cultured primate
astrocytes, accompanied by an increased expression of GFAP and
vimentin (Renner et al., 2013). Although the non-human primate
brain is an important model system essential for studying the
primate brain, it is important to test whether the results can
be generalized to the human brain, especially in the context of
human diseases. Some of the markers that start to appear in both
in vitro and in vivo are described below. The first indication
of the glial specification is marked by induction of nuclear
factor NFIAA/B and GLAST (Araque and Navarrete, 2010)
which appears in embryonic development at E11.5 in the mouse.
Both of these markers remain expressed during glial precursor
migration. Furthermore, GLAST is also expressed in the RG
cells. Other markers such as S100β, FGFR3, FABP7, BLBP, and
SOX9 (which are required for the neuron-glial switch) are not
exclusive, astrocyte-committed markers but are expressed during
neurogenic stages. For instance, while S100β is an astrocyte
progenitor marker, it is also expressed in oligodendrocytes
progenitors (Deloulme et al., 2004; Hachem et al., 2005).
A fascinating issue in this field is how to identify a mature
astrocyte and how to standardize this definition worldwide,
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TABLE 1 | Classification of astrocytes.
Types of
astrocytes
Anatomical locations Cellular morphologies Functions Reference
Protoplasmic
astrocytes
Grey matter Short branched;
Thick processes
• Maintenance of the
blood–brain barrier;
• Regulation of blood flow;
• In synapse formation;
• Neuronal metabolism
Peters et al., 1991;
Bushong et al., 2002;
Nishiyama et al., 2002;
Ogata and Kosaka, 2002;
Oberheim et al., 2006;
Sofroniew and Vinters, 2010
Fibrous astrocytes White matter Thin and straight processes • Maintenance of the
blood–brain barrier;
• Regulation of blood flow;
• In synapse formation;
• Neuronal metabolism
Sofroniew and Vinters, 2010
Interlaminar
astrocytes
Pial surface (humans
and monkey)
Spherical cell bodies • Regulation of calcium wave;
• Thick network of GFAP fibers
Oberheim et al., 2009
Varicose projection
astrocytes
Fifth and sixth layer of
the cerebral cortex
Long processes. (up to
1 mm in length)
Unknown Oberheim et al., 2009,
2012
Epithelial glial cells
(Bergmann glia)
Purkinje-cell layer of
cerebellum
Long processes • Synaptic transmission. Fuller and Burger, 1992;
Olude et al., 2015
Fañanas cells Cerebellar cortex Feather-like arrangement Unknown Fuller and Burger, 1992
Müller cells Retina of juvenile A type of radial glial • Retinal homeostasis;
• Phagocytosis of neural debris;
• Metabolic activity;
• Glycogen within their
cytoplasm
Fuller and Burger, 1992;
Vecino et al., 2015
Pituicytes Neurohypophysis Irregular shaped cytoplasm Unknown Burger and Scheithauer, 1993
Interstitial
epiphyseal cells
Epiphysis Cytoplasmic processes Unknown Fuller and Burger, 1992
Astrocytic domain organization varies with pathology and anatomical locations.
and two laboratories are notable for their work in this area
(Krencik et al., 2011; Roybon et al., 2013). One of the hallmarks
of astrocyte identification is GFAP, the major interfilamentous
protein of a mature astrocyte (Fox et al., 2004). However, while
the expression pattern of GFAP is a sensitive, reliable marker
for most of the reactive astrocytes that respond to CNS injuries,
additional markers such as AQP-4, GS, GLT-1, and GLAST-1
should also be used to study astrocyte differentiation (Kuegler
et al., 2010; Krencik and Zhang, 2011; Krencik and Ullian, 2013;
Kleiderman et al., 2016). A new astrocytic early stage marker,
ALDH1, that selectively labels cortical astrocytes in vivo has
recently been discovered (Rowitch and Kriegstein, 2010) in vivo,
and ALDH1A1 expression has been demonstrated to serve as
a reliable marker in early astrocytic differentiation (Alexandra
Adam et al., 2012). Table 2 summarizes our current knowledge
of astrocyte-specific markers in both human and mouse. For
instance, during early development, immature astrocytes express
mainly vimentin while at the end of gestation period vimentin
is replaced by GFAP in differentiated astroglial cells. However,
additional studies are still needed to clarify the complex roles of
astrocytes.
Astrocytogenesis can also occur in neurogenic hot spots,
correlated with the production of new neurons. In adult rodent
brain, neurogenesis occurs in the SVZ of the lateral ventricle and
the subgranular zone (SGZ) of the hippocampal dentate gyrus
(Ma et al., 2009). Observations that cells with astrocytic markers
(GFAP and S100β; Zhang and Jiao, 2015) begin to emerge in the
granular cell layers of the dentate gyrus (Doetsch et al., 1997;
Kriegstein and Gotz, 2003) are providing new insights into adult
neurogenesis. Moreover, inflammatory and pathological changes
may result in the conversion of astrocytes to neural stem cells.
Whether this also applies to the human brain requires further
investigation (Robel et al., 2011; Dimou and Götz, 2014; Götz
et al., 2015).
ORIGIN OF ASTROCYTES
Gliogenesis generally follows neurogenesis in the developing
brain. Our knowledge on “origin and lineage progression of
human RG” has mainly been extrapolated from rodent studies
due to the limited access of human brain tissue, but recent studies
have begun to uncover unique structural and cellular features
of the primate brain (Duan et al., 2015). The human neocortex
contains around 16 billion neurons of diverse subtypes (Lui et al.,
2011). As the neuroepithelial cells expand the cortical plate, they
form an elongated bipolar cell type, RG cells (Ming and Song,
2005). Transformation of neuroepithelial cells into RG emerges
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TABLE 2 | List of human and mouse astrocyte markers.
Marker Name Role/Localization Reference
Aldolase C (Fructose-bisphosphate aldolase C) Targets glycolysis Li et al., 2013;
Roybon et al., 2013
Aquaporin-4 Perivascular membranes of astrocytes Gee and Keller, 2005;
Kuegler et al., 2010;
Roybon et al., 2013;
Kleiderman et al., 2016
A2B5 (c-series ganglioside-specific antigen) Astrocyte precursors and type 2 astrocytes Dietrich et al., 2002;
Kuegler et al., 2010;
Hayashi et al., 2011;
Kleiderman et al., 2016
Aldehyde dehydrogenase family 1 member L1 ALDH1L1 and GLT1 are co-expressed in the same population of
astrocytes; Appears at mid-embryogenesis
Cahoy et al., 2008;
Rowitch and Kriegstein, 2010;
Roybon et al., 2013
Bystin Stains reactive astrocytes Sheng et al., 2004
Connexin 43 Astrocyte specific marker in the human brain Lovatt et al., 2007;
Fatemi et al., 2008
Glial fibrillary acid protein Low GFAP at a quiescent state and High GFAP in mature state Ghandour et al., 1980;
Rodnight et al., 1997;
Kuegler et al., 2010;
Roybon et al., 2013;
Kleiderman et al., 2016
GLT-1∗ Early astrocytes; Postnatal marker Chaudhry et al., 1995;
Kuegler et al., 2010;
Roybon et al., 2013;
Kleiderman et al., 2016
GLAST 1 Mature astrocytes; Appears at mid-embryogenesis Chaudhry et al., 1995;
Kuegler et al., 2010;
Roybon et al., 2013;
Kleiderman et al., 2016
Nuclear factor 1A Gliogenic switch Roybon et al., 2013
Nestin Reactive glial cells Classic marker
Glycogen phosphorylase Astrocyte specific marker in the human brain Pfeiffer et al., 1992
S100β Early astrocyte marker Burette et al., 1998;
Carlén et al., 2009;
Kuegler et al., 2010;
Kleiderman et al., 2016.
Vimentin Canonical marker Deneen et al., 2006;
Roybon et al., 2013
Based on the available data, this simplified table shows the identified astroglial markers in current trend. The onset of expression varies in different regions of the CNS.
∗ in rodents: Excitatory amino acid transporter 2.
at the beginning of neurogenesis and occurs in humans over
the course of months, while the process only takes “days” in
the rodent brain (Pollen et al., 2015). RG can be distinguished
from neuroepithelial progenitors by the expression of astroglial
markers.
Radial Glial Division
Radial glial are the earliest cells to be derived from the lateral
wall of the neural tube (Anthony et al., 2004; Howard et al.,
2006; Mo et al., 2007) (Figure 1). In humans, RG cells are
also found in the oSVZ in the developing neocortex, which is
absent in rodents (Pollen et al., 2015). The oSVZ contains a
large proportion of outer RG (oRG) cells that act as guides for
neuronal migration. Particularly in humans, the oRG cells appear
to contribute to neocortical expansion by increasing the number
of neural precursor cells (NPCs) (LaMonica et al., 2013).
Radial glial cells usually divide at the apical (ventricular)
surface within the ventricular zone (VZ) to generate new neurons
or single IPC by asymmetric division, or self-amplify progenitors
by symmetric division. The majority of these progenitors migrate
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FIGURE 1 | Origin of human astrocytes from the developing neuroectodermal tube toward mature phase. The neuroectodermal cells give rise to
ependymoblasts which either differentiate into astrocytes or glial membrane on the external side of the neural tube.
radially with the rapid increase in the width of the cerebral wall
(Hartfuss et al., 2001; Marín and Rubenstein, 2001; Anthony
et al., 2004; Götz and Huttner, 2005; Sild and Ruthazer, 2011;
Florio and Huttner, 2014; Schitine et al., 2015). Just before birth,
the RGs “accelerate the expansion of the neuronal population”
and switch to gliogenesis to produce astrocytes. This transition
from neurogenesis to astrogenesis is mediated by known soluble
factors including IL-6 and BMP-4 protein (Miller and Gauthier,
2007). By the end of the cortical development, most of the RG
cells lose their ventricular attachments and migrate toward the
cortical plate to form different cortical layers.
In general, there is a remarkable overlap in the expression
patterns and cell proliferative processes of human and rodent,
but there are species differences in structural organization
and complexity. In mice, the majority of cells form a single
compact layer, whereas in humans they are dispersed throughout
a larger zone. IPCs in human VZ regions can be divided
into two subpopulations, apical and basal, that have discrete
molecular profiles. Apical IPCs are defined by mitosis occurring
at the ventricular surface and the basal IPCs are defined by
mitosis occurring at an aventricular location and the absence
of ventricular contact (Florio and Huttner, 2014). In general,
IPCs can generate neurons (nIPCs) or glial cells, including
oligodendrocytes (oIPCs) or astrocytes (aIPCs). Mouse IPC go
through only one round of cell division to produce two neurons
(LaMonica et al., 2013), whereas human IPC undergo several
rounds of cell division before producing neurons (Hansen et al.,
2010). The molecular mechanisms that underlie IPC division
are still not clear but their transcriptional regulators, such as
TBR2, EOMES are likely involved (Kowalczyk et al., 2009; Fietz
et al., 2010; Hansen et al., 2010). Many reports have suggested
that SVZ in humans can be subdivided into the iSVZ and oSVZ
(Hansen et al., 2010; Lewitus et al., 2013; Thomsen et al., 2016).
A new type of outer radial glia-like cells, basal RGs (bRGs),
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was identified in the oSVZ of developing cortices of humans
(Betizeau et al., 2013; Pilz et al., 2013). The translocation of
RG cells and differentiation to astrocytes has been visualized
through time-lapse imaging (Noctor et al., 2008), as well as a
similar transformation in the sub-cortical telencephalon (Barry
and McDermott, 2005). To date, five different sources of cortical
astrocytes have been identified: (i) RG cells within the ventricular
zone; (ii) RG cell transformation; (iii) intermediate progenitors;
(iv) glial progenitors in marginal zone; and (v) superficial layer
progenitors. However, only a limited number of studies on
astrogliogenesis have been performed in the human (Kanski
et al., 2014; Pas¸ca et al., 2015), in contrast to the numerous
reports on rodents (Chi et al., 2006; Ventura and Goldman,
2007; Widestrand et al., 2007; Demars et al., 2010; Ge et al.,
2012).
MOLECULAR TRIGGERS AND
REGULATORS
Before moving on to consider human astrocyte development
in vitro to generate authentic human astrocytes, we must first
consider the in vivo mechanism.
Inside a human cortex, each astrocyte can be connected
to several thousand neurons to form the neural network. For
instance, each astrocyte can associate with the neural process to
form many neuronal synapses (2,000,000 in humans) (Oberheim
et al., 2009). Astrogenesis is mainly initiated by the activation
of JAK-STAT, the canonical pathway regulating astrocyte gene
expression (Bonni et al., 1997), although multiple signaling
pathways participate (Wen et al., 2009). For example, STAT3
signaling is crucial for astrogenesis, and STAT3 activation
requires the presence of the p300/CBP co-activator complex
to initiate astrocyte gene expression (Freeman, 2010). STAT3
is activated by tyrosine kinases belonging to the Src and
JAK families. This occurs as a consequence of cytokine or
growth factor receptor activation and has been shown to
be relevant for the EGF receptor (epidermal growth factor
receptor), the GCSF (granulocyte colony stimulating factor)
receptor or the IL-6 and CNTF receptors (Moon et al., 2002;
Freeman, 2010). In addition to STAT3, the Notch pathway
is another important regulator of cell fate. Notch activation
directly regulates the HES family of the bHLH gene, inhibiting
neurogenesis during the neurogenic period and promoting
astrogenesis during the gliogenic period (Kageyama et al., 2005,
2008). Other signaling pathways, such as BMP-SMAD, and
Nuclear factor IA (NFIA) can also promote astrogenesis in
the presence of an active JAK-STAT signal (Bonni et al., 1997;
Nakashima et al., 2001; Deneen et al., 2006; Nagao et al., 2007;
Nakanishi et al., 2007; Stipursky et al., 2012). Even though
the mechanisms underlying mammalian astrocyte commitment
have not fully been characterized, this work has shed light on
the essential signaling pathways that are responsible for the
transition.
A combination of several molecules such as TGF-alpha,
CNTF, LIF, IL-6 cytokines, and oncostatin M are required
for astrocyte stimulation in vivo. Other factors such as BMPs
are also involved in determining astrocytic fate. For instance,
a delay or disruption in any of the signaling pathways can
hinder the epigenetic mechanism and timing of neurogenesis and
astrogenesis, eventually leading to perturbations in the relative
ratios of the cell types (Yan et al., 2005; Tidyman and Rauen,
2009).
Generation of Human Astrocyte from
Pluripotent Stem Cells
Examination of human astrocytes from post-mortem tissue have
led to a better understanding of brain diseases and opened doors
toward generating more efficient in vitro based models. The
first human astrocytes were cultured from fetal or adult post-
mortem tissue (Ennas et al., 1992; Lee et al., 1993), but were
often contaminated with microglia and other cell types which
were difficult to separate during dissections. Additionally, in
many cases, biopsies represent the end stage of the disease and
control tissue is obviously inaccessible due to ethical concerns
and potential health risks. Given all the practical limitations
of human brain tissue research, murine and rat astrocytes
have mostly been used to study astrocyte physiology. For this
purpose, murine or rat astrocytes are usually purified from the
cortex. Alternatively, astrocytes may be generated from murine
PSCs (Kleiderman et al., 2016). These generalized approaches
do not account for regional heterogeneity of astrocytes, such
as the expression of the transporter OCT3, which is high in
striatal astrocytes and low in cortical astrocytes (Cui et al.,
2009). Especially for disease studies, astrocytes may therefore
be purified from the relevant brain regions. For instance,
cerebellar, cortical, striatal, and nigral astrocytes show differences
in dopamine or angiotensin signaling (Yu et al., 1996; Reuss
and Unsicker, 2000). Thus, astrocytes from specific brain regions
offer an attractive alternative source to study astrocyte function
in vitro. Mice models offer further advantages since methods
to manipulate the genome (knock-out or knock-in genes) are
well-established. With these approaches it needs, however, to
be considered that astrocyte heterogeneity may not be a cell-
intrinsic property, but be decided by the surrounding neurons,
and may therefore get lost in cell culture (Farmer et al.,
2016).
Comparison of Human and Rodent Astrocytes
The long list of interspecies variation between human and rodent
astrocytes underlines the need for authentic human astrocytes
for disease modeling. Importantly, there are several visible
differences between rodent and human astrocytes:
(i) The average length of astrocytes
Human astrocytes are structurally more complex than mouse
astrocytes (Oberheim et al., 2006, 2009). An investigation of the
total arborization length of mouse and human astrocytes in vitro
found that the average astrocyte process in human was almost
twice as long as that in rodents in vitro (Zhang et al., 2016).
(ii) Average branch numbers
There is a difference in the average branch number in vitro for
humans and rat: 8.5± 1.1 and 4.5± 0.5, respectively (Zhang et al.,
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2016). This dataset was consistent with in vivo measurements
(Oberheim et al., 2009).
(iii) Glial to neuron ration
A much higher ratio of glia to neurons has been estimated for the
human cortex (∼1.65:1) than for rodent (∼0.3:1) (Nedergaard
et al., 2003; Sherwood et al., 2006).
(iv) Different classes of GFAP positive cells
There are only two main types of astrocytes in mouse: fibrous
astrocytes and protoplasmic astrocytes. In addition to these
broad classes, two additional subtypes have been identified in
human and other primates: interlaminar and varicose projection
astrocytes (Colombo et al., 1995; Reisin and Colombo, 2004)
(Table 1).
(v) Gene expression pattern
Only about 90% of the expressed genes in mouse and human
astrocytes overlap (Sun et al., 2013), so there is the opportunity
for unique sets of genes to up-regulate or down-regulate
during astroglial development (Zhang et al., 2014, 2016).
Differences have been found in the glutamate response (Zhang
et al., 2016), and in the use of the TLR/IL-1R receptor and
immune activation. For instance in mouse astrocytes, LPS
induced mostly an A1 effective response, thereby producing
abundant IL-1 protein. In the case of human astrocytes
TLR4 receptor complex proteins and MD2 are expressed
but not CD14 (Tarassishin et al., 2014). These results have
critical implications for translational research of human CNS
diseases.
(vi) Supporting these observations
Supporting these observations, essential differences in vivo
between the two species include in vivo speed of calcium
signaling, which is five times faster in humans (Sun et al.,
2013), and the number of neuronal synapse networks, from
1 × 104 in mouse to up to 2 × 106 in humans (Oberheim et al.,
2012). In vitro, adult human astrocytes responded differently to
extracellular glutamate levels than those of adult mouse, which
remained quiescent under the same conditions (Zhang et al.,
2016).
Most strikingly, various drugs that showed promise in an
animal model have failed in human trials (Cavanaugh et al., 2014;
Cummings et al., 2014). Therefore advancement toward more
human-relevant models is critical for the study of neurological
disorders.
To overcome these obstacles, various laboratories have
elaborated in vitro differentiation protocols to generate astrocytes
from hPSCs. In the early 2000s, hESCs held great promise
and were considered to be the most reliable source for the
generation of human astrocytes and many other neuronal
cell types. However, despite their potential benefits in disease
modeling, the controversial and ethical issue of their derivation
from early embryos remains. Takahashi and Yamanaka (2006)
and Takahashi et al. (2007) published a groundbreaking method
for generating iPSCs using four transcription factor (TF) genes
(Oct4, Sox2, Klf4, and c-Myc) to reprogram somatic cells into
PSCs. The discovery opened new possibilities in stem cell
research providing new and ethically acceptable cell sources for
PSC generation, and making it possible to derive stem cells
directly from patients with different diseases, such as neurological
disorders.
Since the advent of hiPSC technology, several groups
have developed differentiation protocols to obtain human
astrocytes from various pluripotent cell sources (hESCs and
hiPSCs; see details in Table 3), very often adapted from
protocols in published studies (Table 3). These protocols
are continuously being upgraded to improve efficiency and
functionality and differ significantly in multiple aspects (listed
in Table 3), such as the cell seeding density at plating, the
substrate, media composition, the timing and concentration of
exogenous growth factors and morphogens, and the physical
dimensions of the culture system (monolayer or embryoid
bodies). These differences which might seem small at first
glance make it very complicated to compare the outcome of
the different methods. In this section, we aim to examine some
of the most commonly used techniques in human astrocyte
differentiation to provide a point of reference (also summarized
in Table 3).
To establish a reproducible platform and to study astrocyte-
neuronal interaction, protocols first have to generate stable
human NPC populations. During organismal development, the
fate of the respective cell types is determined by the exact timing
and concentration of growth factor/patterning signals at given
locations. With knowledge of the patterning signals, in vitro
astrocytogenesis of defined subpopulations could be achieved by
exposing human PSC-derived primitive neuroepithelia to a set
of diffusible signaling molecules, directing their differentiation
into subpopulations that would arise in vivo in discrete regions
along the neural tube. This process could generate functionally
diversified classes of glial cells. A similar approach is commonly
used for neurons (Kirkeby et al., 2012). For instance, FGF
and RA determine rostro-caudal identity, whereas Wnts, BMPs,
and Shh are required to specify NPCs along the dorso-ventral
axis. We know that astroglial progenitors generated in the
absence of mitogens carry a dorsal-anterior identity by expressing
Otx2 but not Hoxb4 or Nkx2.1, while astroglial progenitors
generated in the presence of RA express Hoxb4 but not Otx2
(Liu and Zhang, 2011). To mimic the in vivo mechanisms
governing early neurogenesis (NPC formation), two major
classes of protocols are utilized: an EB-based technique (with
or without SMAD inhibition) and a monolayer-based dual
SMAD inhibition method. Most protocols use aggregation of cells
into EBs, and only a few rely on a monolayer-based adherent
culture system (Shi et al., 2012; Roybon et al., 2013). The 3D
aggregation system is thought to maintain the “stemness” of
stem cells and to allow better cell-to-cell and cell-to-matrix
interactions. Other vital considerations for improved neural
cultures are media composition, exogenous growth factors or
small molecules, and most importantly the timing of the
procedure itself.
The Neural Induction Protocol
The neural induction protocol involves in dissociating PSCs and
plating them on a feeder or feeder-free adherent culture system.
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The media for neural induction usually consist of the neurobasal
medium or DMEM/F12 medium, or combination of both. The
cells are rapidly induced with antagonists, either LDN or noggin
to inhibit the BMP pathway and SB431542 to inhibit the TGF-ß
pathway, along with additional components to enhance neuronal
precursors (Chambers et al., 2009) (Figure 2). The primitive
neuroectodermal aggregates (3D system) or neuroepithelial
sheets (2D system) are then plated on the adherent substrate to
promote the definitive neuroectoderm fate. Upon reaching the
“end phase,” NPCs are organized into polarized structures called
neural rosettes. These neural rosettes are selected and cultured for
several passages and then directed toward astroglial progenitors
with different combinations of morphogens (CNTF, SHH, FGF,
and RA) in defined culture medium. Numerous studies have
utilized each of these methods, often with minor variations.
However, it is not always clear why a particular method was
chosen, and so it is very difficult to evaluate the exact effect of
these small changes. In the next section, we have summarized
the most efficient ways to generate human astrocytes from PSC-
derived NPCs through in vitro culture, and discuss the maturity
of the derived astrocytes.
For neural differentiation of hESCs, most of the available
methods are based on either the initial formation of embryoid
bodies or on co-culture with stromal cells. First, we would
like to compare the aggregate differentiation from monolayer
differentiation.
hESCs Studies on Embryoid Bodies
Zhang et al. (2001) was the first to develop a novel technique to
isolate and culture human astrocytes in serum-free conditions,
thus recapitulating the resting, non-reactive state normally
observed in healthy astrocytes in vivo, and went on to describe
a differentiation technique for human ES cells that can be
applied to model and study fetal and mature astrocytes in
health and disease. In their first report (Zhang et al., 2001),
differentiation was initiated by culturing the cells as 3D
spheres in chemically defined medium containing FGF-2 for a
short period. Subsequently, the EBs were grown in adherent
culture to form neural rosettes. This unique cross-sectional
arrangement of epithelial cells is now considered a hallmark of
successful neural induction. By day 7, almost all EBs generated
neural tube structures to produce neural progenitor cells and
neural stem cells, and morphological analysis confirmed the
expression of neural markers Nestin, Musashi-1 and neural cell
adhesion molecule (NCAM). This group were the first to show
the incorporated hESC-derived neural precursors in different
brain regions upon transplantation into the neonatal mouse,
with no teratoma formation. This remarkable development
generated GFAP+ astrocytes, oligodendrocytes both in vitro and
in vivo.
In the same year, two other EB based differentiation studies
were published (Carpenter et al., 2001; Reubinoff et al., 2001).
Both studies also used hESCs in a 3D aggregate culture system
in the presence of FGF-2 to induce neural differentiation. In
one, EBs were differentiated into neuronal progenitors in the
presence of RA along with selective morphogens (Carpenter et al.,
2001) (detailed in Table 3), while in the other, differentiation
occurred in the presence of just EGF and FGF-2 (Reubinoff et al.,
2001). Therefore both the studies obtained populations with a
wide panel of morphological characteristics, such as positive for
Nestin, PS-NCAM, and A2B5. FACS analysis revealed 96% of the
cells were positive for A2B5 (a marker for astroglial progenitors)
(Carpenter et al., 2001).
hESCs Studies on Monolayer
Later, Tabar generated a neural progenitor population by
inducing hESCs on stromal cells (MS5) in serum-free media
(Tabar et al., 2005). To enhance the neural induction noggin was
added to the N2 media. After a month neural precursors were
isolated and maintained in N2 media containing FGF-2 and EGF.
At this stage, the majority of cells (>90%) were immunoreactive
for neural precursor markers (Nestin, Musashi-1) and a glial
progenitor marker (A2B5).
A better understanding of differentiation protocols has led
us to conclude that the majority of hESC studies utilize the
classic aggregation method to yield functional astrocytes in
combination with different growth factor cocktails. Despite the
potential benefits of hESC technology, the direct differentiation of
hESCs toward astrocytes is rarely undertaken, for ethical reasons.
Therefore we now compare some of the available protocols from
human iPSCs technology (detailed in Table 3 and Figures 3A,B).
For neural differentiation of hiPSCs, most methods available
are either based on the initial formation of embryoid bodies or
monolayer base methods.
hiPSCs Studies on Embryoid Bodies
Differentiation of hiPSC-derived NSC into astrocytes was first
reported following the observation that astrocyte progenitor
cells were S100β positive after four weeks of differentiation
and GFAP positive around the 12th week of differentiation
(Hu et al., 2010). The study used a similar aggregated
differentiation method to that of Zhang et al. (2001) to
obtain neurons. To further enhance the glial differentiation
the progenitors were expanded in N2B27 media containing
additional factors, i.e., cAMP, T3, platelet-derived growth
factor (PDGF), Insulin-like growth factors (IGFs), and
neurotrophin-3 (NT-3), with the aim of increasing the formation
of OLIG2 positive ventral progenitors and reducing the
formation of HB9+ postmitotic motoneurons (Hu et al.,
2010).
In the subsequent years, additional studies have described
the generation of astroglial cells from human PSCs, including
a landmark study that generated functional astrocytes from
iPSC that were indistinguishable from hESC-derived astrocytes
(Emdad et al., 2012). The study involved culturing EBs on
low attachment plates in neurobasal media for 2 weeks to
develop columnar epithelium within the formed EBs. And also
investigates the astrocyte differentiation potential with three
different conditions: (1) CT-1 alone, (2) CT-1 in combination
with CNTF, and (3) recombinant Jagged-1 (JAG1-Fc) in
conjunction with CNTF. The results have showed high number of
hiPSC-derived NE cells after sequential treatment with FGF- 2+
CNTF followed by CNTF alone. However, no incremental effect
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FIGURE 2 | Differentiation of PSCs toward astrocytes. Once the neuro-progenitors are produced from pluripotent stem cells, addition of selection factors can
lead to the generation of mature astrocytes or astrocytes precursor (Jha et al., 2015).
on astrocytic differentiation was observed when CT-1, Notch
activator JAG1-Fc was used.
Later, Lafaille described the efficient generation of astroglial
cells within 10 weeks (Lafaille et al., 2012), adapting previously
described protocols to enhance neural differentiation (Zhang
et al., 2001; Elkabetz et al., 2008). The derived neural crest stem
cells (NCSc) and NPCs from hPSCs were expanded in defined
conditioned medium supplemented with EGF and FGF-2 for
8 weeks, followed by 5% FBS treatment for 20 days, leading to
90% GFAP+ cells.
The next study went on to show the efficient generation
of astroglial cells within the short time frame of 6 weeks
from hPSC-derived NSCs, using a defined medium system
(Shaltouki et al., 2013). As might be expected, the differentiation
protocol was EB based, with the colonies cultured in
suspension for 8 days before surface attachment. Formed
neural rosettes were manually isolated and replated to
acquire a homogenous population of NSCs, that was then
stimulated with neurotrophic factor (CNTF) and proteins
(BMP, FGF-2) to significantly increase the proportion of
GFAP positive cells. These differentiated astrocytes were
then plated on neurons to quantify synapse formation.
Interestingly, the number of synaptic puncta remained
significantly higher in the presence of astrocytes, indicating
that these in vitro astrocytes displayed similar functional
characteristics and morphological patterns to primary
astrocytes.
Other studies have added further evidence for the generation
of astroglial cells. Sareen et al. (2014) generated so-called
“EZ spheres” from hiPSCs that could be differentiated into
neural progenitor cells with an astroglial predisposition.
The “EZ sphere” is a free-floating cell aggregate containing
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pre-rosette stem cells, that is generated directly from PSCs.
The EZ spheres were caudalized using all-trans-RA in
neurobasal medium and maintained their proliferative
capacity for 30 passages. For astroglial differentiation, they
were dissociated and plated as single cells (Sareen et al.,
2014). Like Sareen, the study by Serio et al. (2013) opted
for EZ sphere formation; neurospheres were mechanically
chopped at the beginning of the enrichment phase and
cultured in neurobasal medium for 2–4 weeks, before being
dissociated to form NPCs. Astrocyte populations were obtained
by differentiating NPCs in CNTF (Serio et al., 2013). The
resulting population robustly expressed both developmental
FIGURE 3 | Continued
Frontiers in Cellular Neuroscience | www.frontiersin.org 14 September 2016 | Volume 10 | Article 215
fncel-10-00215 September 22, 2016 Time: 14:46 # 15
Chandrasekaran et al. Astrocyte Differentiation of hiPSCs
FIGURE 3 | Comparison of different protocols for deriving astroglial cells from human pluripotent stem cells. (A) Generation of astroglial cells from 3D
aggregates or neurosphere through neural progenitor’s cell stage. iPSCs are dissociated at day 1 and cultured as aggregates in suspension. Aggregates are replated
onto culture dish to form primitive neuroepithelial structures. Upon reaching definitive NE structures are manually isolated and replated for progenitors. (B) Methods
based on neuronal rosette selection. Rosette structures are mechanically harvested and replated in appropriate growth factors for specific progenitors
(C) Spontaneous emergence approach. Endogenous astrocytes gradually emerge over time, say after 40 days.
(Nestin, vimentin, GFAP) and mature astrocyte markers
(S100β).
The most striking feature of these studies is the formation
of the EZ sphere (∼200 µm) which represents the primitive
type of neural stem cells at a stage before early neural tube
formation. While various protocols exist for the generation
of PSC-derived neural progenitor cells, including the complex
four stage systems involving RA-mediated induction, adherent
culture, and neural rosette isolation, all these methods can be
laborious when compared to EZ sphere formation.
Mormone and co-workers then generated iPSC-derived
astrocytes with characteristics similar to those differentiated
from hESCs by culturing clusters of cells in low attachment
plates in the presence of neurobasal media supplemented with
different factors such as FGF-2, EGF, and CNTF, at various
time points. Cells were then subjected to immunopurification
via magnetic cell sorting for the “positive selection of A2B5
cells,” before being plated in neurobasal medium containing
CNTF for an additional 2 weeks. A2B5 is mostly expressed
in embryonic neural tissue and is therefore considered to be
a marker for immature glial-committed precursors that give
rise to glial types such as astrocytes and oligodendrocytes.
The authors reported 99% GFAP-positive cells at fourth
week of differentiation with the absence of teratoma
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formation in long-term experiments (Mormone et al.,
2014).
hiPSCs Studies on Monolayer Base
Methods
Roybon et al. (2013) generated two subpopulations of human
astrocytes in vitro: the first subpopulation was generated from
stem cells (derived from human PSCs) and was capable
of an immunological response similar to human primary
astrocytes, while the second subpopulation contained mature,
quiescent astrocytes (Roybon et al., 2013). When co-cultured
with MNs, these astrocytes also enhanced neuronal survival
and neurite outgrowth. Strikingly, they also found that
the addition of either FGF1 or FGF2 was sufficient to
promote transitions, maturation/quiescence without triggering
inflammatory responses (TNFα or IL-1). It should be noted
that although the majority of the existing protocols administer
FGF2 into the media (Table 3), the exact role of FGF2
in in vitro astrocyte differentiation is uncertain. There is
evidence to suggest that FGF-2 has an additional feature in
gliogenesis beyond driving the propagation of neural stem
cells both in vitro and in vivo. The possible mechanisms of
action are: (i) FGF2 in combination with a second factor
(e.g., CNTF or BMP2), but not FGF2 alone, may trigger
astrocytogenesis; (ii) FGF2 may trigger early commitment of
NSC to astrocytes, but is not sufficient to transform the cells
to astrocytes; or (iii) astrocytogenesis may be a stressful process
for NSC, and the presence of FGF2 keeps the cells alive
and proliferative, while other factors could decide the way of
the differentiation (Song and Ghosh, 2004; Kang and Song,
2010).
Emerging Trends in Astroglial
Differentiation
The strategy to recapitulate neurogenesis and astrogenesis during
early development has gained increased attention in modern
science. The generation of human RG-type cells from PSCs
in a chemically defined medium without adding morphogens
validates that cultured hRGs maintain a cell-intrinsic clock that
regulates the progressive generation of stage-specific neuronal
and glial subtypes (Duan et al., 2015). One step further, a
3D culture approach for generating human cortical spheroids
(hCSs), a laminated cerebral cortex-like structure, from PSCs
initially showed only a few GFAP positive cells after 35 days
of differentiation. This later increased to 8% on the 76th day
and almost 20% after 180th day (Pas¸ca et al., 2015). Finally,
Caiazzo et al. (2014) demonstrated that the direct conversion
of human fibroblast by overexpressing a defined group of
TFs (NFIA, NFIB, and SOX9) led to the rapid single-step
generation of human induced astrocytes. The study makes use
of inducible TFs which are selectively expressed in astrocytes.
Unlike any other studies, this research indicated a direct
reprogramming process with no intermediate states resembling
either ESCs or NSCs. To our knowledge, this is the first
report that shows astrocyte-like cells derived from fibroblasts
by entirely skipping the iPSC generation. The expression of
astrocyte marker proteins (S100β and GFAP) was detected in
induced astrocytes. However, further experiments are required
to prove the functional similarity to human astrocytes (Caiazzo
et al., 2014). Therefore, regardless of approach, it is a matter
of generating authentic RG-like NSC/NPCs which can be
further differentiated into astroglial-like cells. To obtain a more
gliogenic NSCs/NPC type, it is, therefore, necessary to induce
the differentiation with RA and subsequently immune-isolate
for CD133-positive cells. This principle was shown for human
cells (Gorris et al., 2015) and murine cells (Kleiderman et al.,
2016).
Astrocyte Maturation Studies
Astrocyte maturation occurs through a series of complex
events, which remain poorly understood. Some reports have
suggested that IL-6 family cytokines (such as LIF, CNTF)
(Bonni et al., 1997) or BMPs (BMP2, BMP4) (Gross et al.,
1996) have a comparable potential to induce differentiation
of astrocytes from neural progenitor cells. Some published
protocols have achieved astroglial maturation by culturing cells
in the presence of different combinations of FGF-2, EGF, and
CNTF for changing time periods (Emdad et al., 2012). Others
have achieved astrocyte maturation by any of the following
combinations: (i) maintenance media along with 10% fetal
bovine serum (FBS) (Palm et al., 2015); (ii) maintenance
media in the presence of BMP-4 (preferably for rodents); (iii)
maintenance media with CNTF; or (iv) maintenance medium
with bFGF, NT3 and/or PDGF-AA (Juopperi et al., 2012;
Haas and Fischer, 2013; Tanga et al., 2013). These methods
can generate robust populations of functionally diversified
astrocytes with high efficiency, based on staining for β-III-
tubulin, GFAP, and AQP4, but their functional maturation and
efficacy varies considerably among different studies and cell
lines.
Spontaneous Emergence Approach
Astrocytes can also emerge spontaneously in neuronal cultures
by the “spontaneous emergence approach” (Figure 3C). For
example, human iPSC-derived NPCs have been differentiated
toward various neuronal lineages such as cortical neurons
(Li et al., 2009), midbrain dopaminergic neurons (Yan et al.,
2005) and spinal MNs, where astrocytes and oligodendrocytes
frequently appear as side products in these preparations,
however, the efficiency is low and not reliable. A numbers
of protocols have been derived from this approach. A recent
study showed the emergence of endogenous astrocytes from
neuronal cultures via increased expression of the glial fibrillary
acidic protein (GFAP), a marker of astrocytes, at day 100,
with confirmation through the NanoString platform (Muratore
et al., 2014). Other groups have also confirmed the emergence
of astrocytes with long-term differentiation of hiPSCs-derived
neural progenitors (Shi et al., 2012; Espuny-Camacho et al.,
2013). A new 3D based protocol published by our group was
able to generate neuronal cultures enriched in GFAP+ and
Aquaporin-4+ astrocytes (Zhou et al., 2016). However, all of
these protocols are complex, time-consuming, difficult to expand
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and have fewer functional properties than the in vivo models or
directed approach.
Toward a Standardization of Protocols
The generation of astrocytes from human PSC has reached a
state where the cells can be considered for clinical applications
and various research questions. It is now important to take
stock, to identify remaining research needs and to work toward
protocols that provide standardized sets of cells. Concerning
the latter point, it would be important to develop consensus
criteria of how a ‘high quality astrocyte population’ should
be defined. Such criteria will need to account for different
applications of the astrocytes. For instance, the requirements for
cells intended for transplantation will be different from those
required for pre-clinical target discovery, or disease modeling,
or construction of in vitro 3D tissues. However, in all instances,
the cell population will need to be characterized for: (i) purity
according to positive markers and also for negative markers; (ii)
for maturity/region-selectivity, e.g., by using markers, secretion
of growth factors and/or gene expression profiling; (iii) function,
e.g., by functional assays like looking at glutamine synthesis
or inflammatory activation or by quantifying the support of
neuronal growth and synapse formation; as well as (iv) cell
cycle state - most of the cells should be non-proliferative.
To our knowledge, none of the available protocols has been
fully characterized for all this information, and each available
protocol still has drawbacks: (i) some of the protocols do
not provide sufficient detail for reproduction; (ii) astrocyte
purity and maturity is not comparable to that obtained with
primary isolated astrocytes; (iii) there are technical issues that
prohibit widespread use, even though the protocol may be
suitable (e.g., long-term induction process that might result
in >120 days protocol to generate astrocytes); and (iv) the
emerging astrocytes are often poorly characterized (e.g., are
only stained for classic markers such as GFAP and S100β),
but hardly for maturity markers, regional identity, negative
markers and additional astrocyte functional characterization.
Some astrocytes have been generated from PSC in the presence
of patterning molecules known to shape the nervous system.
In this way either spinal cord phenotypes (Krencik et al.,
2011; Roybon et al., 2013; Serio et al., 2013; Sareen et al.,
2014) or astrocytes with forebrain identity have been generated
(Shaltouki et al., 2013). However, most studies have not explored
the region-specific phenotype of the astrocytes generated
in vitro.
For this reason, there is no protocol at present that has become
a gold standard, and there is still a need both for further protocol
optimization and for better characterization and standardization
of the resultant cell types.
ASTROCYTES IN NEUROLOGICAL
DISEASES
Since the importance of astrocytes for functional neuronal
networks has long been underestimated, it is not surprising that
their central role in many neurological disorders was equally
neglected. Experiments on mouse models of human neurological
diseases including diverse neurodegenerative diseases (e.g.,
AD, ALS, Parkinson’s disease, and spinocerebellar ataxia) and
neurodevelopmental disorders (e.g., Alexander’s disease, Autism
spectrum disorders, Epilepsy and Rhett syndrome) have led to
advances in understanding astrocyte biology (Table 4, for the
overview of pathological affected gene defects). In most of the
diseases, however, it remains unclear whether the pathologic
changes are caused by astrocytes or rather a consequence of
preceding events.
It is worthwhile to mention the success of iPSC
technology in regards to neural-glial disease modeling
including Parkinson disease (Rhee et al., 2011; Sánchez-
Danés et al., 2012), demyelination (Tokumoto et al., 2010;
Czepiel et al., 2011; Pouya et al., 2011), retinal regeneration
(Parameswaran et al., 2010; Tucker et al., 2011), nerve
degeneration (Wang A. et al., 2011) and various others
(Saporta et al., 2011). Recent studies by Chen et al. (2014)
shed light on understanding the disease phenotypes of DS
using an iPSC tool. This study tested minocycline (an FDA
approved drug) to correct the pathological phenotypes of
DS astroglia. Notably their results demonstrated higher
levels of GFAP/S100β expression as compared to control
astroglia. Therefore iPSCs technologies are now considered
to be a valuable platform to model diseases and improve
our understanding of pathomechanisms. Furthermore, they
can be employed for drug screening and testing. In the
following section, we would like to discuss some of the
diseases that could see, or already have seen, benefits from this
technology.
Alexander Disease (AxD)
Alexander disease is a progressive astrogliopathy caused by
a dominant gain-of-function mutation in the GFAP gene
that maps to chromosome 17q21 (Brenner et al., 2009).
It is a primary disease of astrocytes that affects neural
development and causes mental retardation, seizures, and
megaencephaly in early childhood. There are three age-
dependent clinical subtypes of AxD: infantile, juvenile
and adult-onset. Infantile AxD is very aggressive and is
characterized by seizures, and bulbar dysfunction with low
life expectancy. Juvenile AxD is characterized by hyperreflexia
and bulbar symptoms affecting children between 2 and
14 years of age, and is milder than the infantile form. Adult
AxD which affects the late adolescence and beyond, has
similar characteristics to the juvenile form (Prust et al.,
2011).
In this disease, there is no known metabolic abnormality.
Pathophysiology reveals abundant astrocytic accumulations of
eosinophilic cytoplasmic inclusions, known as RF, one of the
hallmarks of AxD (Molofsk et al., 2012). RF are protein
aggregates composed of Vimentin, GFAP and small heat shock
proteins that are present in the cytoplasm of astrocytes. The
clinical signs of AxD are likely due to astrocyte dysfunction
rather than astrocyte loss (Messing and Goldman, 2003). In
vitro studies have provided additional clues that astrocyte-
mediated effects in AxD are due to oxidative stress and
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TABLE 4 | Summary of the astrocyte-affected diseases.
Astrocyte
affected
disease
Astrocyte associated defects or gene
defects
Astrocytes mediated pathological or
neurological features
Reference
Hepatic
encephalopathy
Astrocyte swelling and neurotransmitter
receptor alternation
Cytotoxic brain oedema Felipo and Butterworth, 2002;
Butterworth, 2010;
Chen et al., 2012;
Takayama, 2015
Neuromyelitis
optica (NMO)
Auto-antibody; loss of aquaporin 4+ and
GFAP+ astrocytes
Inflammation, demyelination, astrocyte loss and
nerve injury
Lennon et al., 2004;
Wingerchuk et al., 2007;
Marignier et al., 2010;
Tradtrantip et al., 2012
Balo’s disease Loss of aquaporin4+ and CX43 Demyelination and astrocyte hypertrophy Tokumoto et al., 2010;
Czepiel et al., 2011;
Pouya et al., 2011;
Linnoila and Chitnis, 2014
Wernicke’s
encephalopathy
Loss of EAAT1 (GALST) and EAAT2 (GLT-1);
decreased level of aquaporin 4
Loss of neurons, oedema, gliosis Sechi and Serra, 2007;
Lough, 2012
Alexander
disease (AxD)
Mutation in GFAP protein Accumulations of eosinophilic cytoplasmic
inclusions, known as RF
Prust et al., 2011;
Wang L. et al., 2011;
Molofsk et al., 2012;
Lanciotti et al., 2013
Alzheimer
disease (AD)
Synaptic loss and neuronal death Deposition of extracellular SPs and
neurofibrillary tangles
Wyss-Coray et al., 2003;
Koistinaho et al., 2004;
Castellano et al., 2011;
Li et al., 2011;
Sidoryk-Wegrzynowicz et al., 2011;
Israel et al., 2012;
Kondo et al., 2013
Vanishing white
matter (VWM)
Autosomal recessive neurological disease,
Mutation in eIF2B, eIF2B is a guanine
nucleotide-exchange factor for eIF2
Gray matter remains normal, whereas white
matter changes texture. Abnormally shaped
astrocytes with febrile infections
La Piana et al., 2012;
Elroy-Stein and Schiffmann, 2014
Megalencephalic
leukodystrophy
Is an early-onset macrocephaly,
Degeneration of motor functions
Intramyelinic vacuole formation, alterations of
the blood–brain barrier structure and astroglial
activation
Anand et al., 2007;
Brignone et al., 2014
Aldh1L1, aldehyde dehydrogenase 1.
reduction in the GLT-1. Therefore these observations suggest
a possible pathogenic mechanism underlying neuronal loss
in AxD. Other possible astrocytic failures that contribute
to myelin degeneration in AxD are K+ buffering, and
Na+/K+ATPase activity (Lanciotti et al., 2013). To address
the clinical importance of astrocyte dysfunction in AxD,
there is a critical need for the new model system, as
so far only a Drosophila model exists (Wang L. et al.,
2011).
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic lateral sclerosis is an adult-onset neurodegenerative
disease manifested by degeneration of MNs in the motor
cortex, brain stem, and spinal cord, resulting in muscle
paralysis and ultimately motor neuronal death (Rowland and
Shneider, 2001; Kiernan et al., 2011). Most of the cases
of ALS are sporadic with unknown genetic mutation; only
about 5–10% of ALS cases are caused by known genetic
mutations, among which 20% are caused by mutations
in the copper/zinc SOD-1 gene. Mutations of SOD1 were
identified through an autosomal-dormant inheritance pattern
(Rosen et al., 1993). Gurney et al. (1994) were the first to
recapitulate the hallmarks of ALS using a transgenic mouse
model (SOD1 G93A mutant mouse) that expresses human
copies of SOD1 enzyme with glycine-alanine substitution at
the 93rd codon of the coding sequence (Gurney et al.,
1994; Rothstein et al., 1995). Over the years, a variation of
SOD1 mutants have been subsequently developed as G37R,
G85R, and G86R transgenic; although these models differ
in protein content, they develop the same MN degeneration
that is characteristic of ALS (Turner and Talbot, 2008). In
the past two decades exhaustive efforts have been made
to significantly improve the understanding of ALS disease,
and at least eight variations of the disease have now been
identified (ALS1–ALS8) indicating the complexity of MN
degeneration. At present, the G37R, G85R, and G86R transgenic
models are considered to be the most reliable and accurate
animal models of ALS, where they have been extensively
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used in understanding the mutation of SOD1 that causes cell
death.
Despite the improvement in understanding ALS pathogenesis
from the use of transgenic models, there is still a lack of
understanding of, or effective treatment for, ALS disease.
However, modeling ALS using rodents with an ALS-carrying
mutation only represents a subset of the disease, and since
ALS is a slowly progressive neurodegenerative disease, modeling
ALS using transgenic animal models requires months of study
which results in increased cost. To overcome these limitations,
the research community has shown keen interest in using iPSC
models for ALS disorders. Recent studies have emphasized
the involvement of astrocyte dysfunction in the pathogenesis
of ALS. One of the standard features of both familial and
sporadic ALS is the loss of astrocyte GLT-1, (EAAT2) from the
synaptic cleft; regulating synaptic transmission and preventing
glutamate excitotoxicity. Supporting the hypothesis of MN
degeneration caused by excitotoxicity (Barbeito et al., 2004).
Multiple groups have performed ALS iPSC disease modeling
from patients with familial and sporadic ALS (Chestkov et al.,
2014; Liu et al., 2014). Work by Krencik et al. (2011) in
was significant in broadening the tools for ALS research by
demonstrating that astrocytes could be generated from human
ESCs. When astrocytes generated from hPSCs were transplanted
into the lateral ventricles of neonatal mice, they observed that
the regional identity specified in vitro was retained. Strikingly,
the transplanted cells also developed end-feet suggesting that
these cells were able to contribute in the formation of the
BBB (Krencik and Ullian, 2013). Recently, astrocytes directly
reprogrammed from ALS patients carrying TARDBP mutations
showed abnormalities typical of a TDP-43 proteinopathy,
including its cytoplasmic mislocalisation. Imaging of mutant
astrocytes revealed that TDP-43 mislocalisation decreased
cell survival, suggesting that mutant TDP-43 is responsible
for astrocyte pathology. Apparently, mutant astrocytes were
not toxic when co-cultured with either control or mutant
TARDBP MNs (Serio et al., 2013). In two other reports
hiPSCs were utilized to study SOD1 mutation in MNs.
Kiskinis et al. (2014) used high-resolution RNA sequencing
technologies to identify the transcriptional and functional
changes induced by the SOD1A4V dominant mutation in
human MNs and found that the expression of mitochondrial-
related (Jiang et al., 2013) and ER-stress-mediated genes
were significantly reduced. While the other study by Chen
et al. (2014) discovered an autonomous behavior of mutated
SOD1 in MNs caused by destabilization of neurofilament
subunits.
Hepatic Encephalopathy (HE)
Hepatic Encephalopathy is another example of how astrocyte
dysfunction can cause a neurological disease. HE accompanies
both acute and chronic liver failure and is characterized by
the accumulation of ammonia in the brain that is detoxified
by astrocytic GS, resulting in increased osmotic forces, which
then leads to cytotoxic oedema and astrocyte swelling. It
seems that altered neurotransmission is responsible for the
excessive ammonia levels that lead to the cognitive and motor
impairments seen in patients with HE. In the brain of HE
patients, neurons appear to be morphologically normal, but
astrocytes show signs of Alzheimer type II degeneration, i.e.,
nuclear enlargement, prominent nuclei, chromatin changes, and
neurotransmitter receptor alteration (Felipo and Butterworth,
2002; Butterworth, 2010). There have been some animal
studies evaluating BBB integrity in acute liver failure, but
there has been less research on this subject conducted on
humans. To our knowledge, Chen et al. (2012) evaluated the
hepatoprotective property of 3-genes iPSC transplantation in
a carbon tetrachloride (CCl4)-induced AHF model in mice.
Their findings revealed that 3-genes iPSC-based therapy not
only improved hepatic functions and animal survival, but
also improved CCl4-induced HE. After Chen’s group (Chen
et al., 2012), there have been only limited reports addressing
the functionality of hepatic cells derived from hiPSCs/hPSCs
(Takayama, 2015).
Alzheimer’s Disease (AD)
Alzheimer’s disease is characterized by the progressive
deterioration of cognitive functions such as memory and
mental processing. Most cases of AD are sporadic, but about
1–2% are genetically linked with the early onset (EOAD) of
dementia. There are two major histopathological hallmarks in
the brain of AD patients, the deposition of extracellular SPs
composed of the Aβ peptide, and neurofibrillary tangles, which
are intracellular inclusions of hyperphosphorylated tau protein
in selective regions of the brain (Sidoryk-Wegrzynowicz et al.,
2011). SPs are deposits of extracellular Aβ protein derived
from Aβ42, a peptide fragment of 42 amino acid residues
derived from the sequential step of proteolytic processing
of amyloid precursor protein by β and γ secretase. As the
disease progresses, synaptic loss and neuronal death become
prominent, which consequently lead to the shrinkage of the
brain.
The best-studied risk factor for sporadic, LOAD is the
presence of ApoE (APOE ε4), a protein involved in lipid
metabolism. The presence of one APOE ε4 allele increases
the risk of LOAD by threefold while two alleles of APOE
ε4 can increase the risk for late-onset AD by 12-fold.
Multiple studies from various populations have confirmed the
increase in LOAD is caused by the presence of an APOE-
ε4 allele. In contrast, APOE-ε2, another variation of this
allele, confers protection against developing AD. A recent
finding suggests that astrocytes play a significant role in the
clearance of the Aβ peptide thus preventing the formation
of plaques in the healthy brain (Wyss-Coray et al., 2003;
Li et al., 2011). The precise mechanism by which astrocytes
recognize and degrade Aβ is not known, but ApoE which
is primarily expressed in astrocytes and to a lesser extent in
microglia has been proposed to be responsible for this cellular
action (Koistinaho et al., 2004; Castellano et al., 2011). The
importance of APOE ε4 in AD has been well established,
although further studies are needed to understand the exact
molecular mechanism that leads to an increased susceptibility
for AD.
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TABLE 5 | Use of human astrocytes generated from pluripotent stem cells for disease modeling and pathology research.
Disorder Phenotypes Culture methods Potential applications Reference
Amyotrophic lateral
sclerosis (ALS)
Down regulation of VAPB
expression, failure of motor
neurons
By either direct reprogramming
or iPSC-derived NPCs
Generated functional astroglia from human
induced pluripotent stem cells (iPSCs)
carrying an ALS-causing TDP-43 mutation
Serio et al., 2013
Human iPSC-derived astrocytes showed an
increase in Cx43 protein,
Almad et al., 2016
Rett syndrome (RTT) Fewer synapses, reduced
dendritic spine density, and
soma size
iPSC-derived NPCs –RTT-iPSCs showed the recapitulation of
RTT phenotypes.
–MeCP2 seems to have an essential
function in astrocytes
Dajani et al., 2013
Alzheimer disease (AD) Intracellular accumulation of
Aβ, increased ROS
production, ER stress
Embryoid body formation by
dual smad molecules
Kondo et al., 2013
Huntington disorder Trinucleotide repeat
expansion (CAG) in exon 1
of huntington (HTT)
iPSC-derived NPCs –Generated adult form of HD (F-HD-iPSCs).
–Identified a cellular vacuolation phenotype
similar to HD patients.
Juopperi et al., 2012
Another significant aspect of AD pathogenesis is the
interaction of microglia and astrocytes through the production
of neurotoxic molecules. The role of astrocytes in inflammatory
processes is complicated to address, though activated
astrocytes are capable of phagocytosis. Activated astrocytes
are characterized by hypertrophic somata in neurodegenerative
diseases. The process of astrocyte activation results in reactive
gliosis, which appears in late stage AD. Reactive astrogliosis
in AD can be triggered by various elements, including
damaged neuronal signaling and extracellular deposition
of the β-amyloid peptide. Once substantial accumulation
occurs, astrocytes themselves undergo apoptosis resulting
in the formation of amyloid plaques positive for GFAP
and S100 β. Recently, iPSC-derived neurons from different
patients were found to show different accumulation of Aβ
oligomers in AD models (Israel et al., 2012; Kondo et al.,
2013) Therefore the use of iPSC-derived AD model can
act as a testing platform for the optimal pharmacological
regimen.
Neuromyelitis Optica (NMO)
Neuromyelitis Optica is a primary astrocytopathy disease
affecting the CNS. NMO was first described in the 19th century
and was long considered to be a variant of multiple sclerosis.
Pathological descriptions such as the frequent occurrence
of necrosis with cavitation are used to distinguish NMO
from multiple sclerosis (Marignier et al., 2010). The disease
is commonly associated with diffuse cerebral white matter
lesions that resemble acute disseminated encephalomyelitis,
and severe demyelination affecting the optic nerve and
spinal cord. The evidence of this disease reveals the loss of
neurons and astrocytic damage (Wingerchuk et al., 2007).
AQP-4 is one of the most valuable tools for the diagnosis
of NMO (Lennon et al., 2004), and a novel potential
therapeutic approach using a recombinant monoclonal anti-
AQP4 antibody that selectively inhibits NMO-IgG binding
to AQP-4 has been proposed (Tradtrantip et al., 2012).
This study demonstrates a direct way in understanding the
pathogenesis of autoimmune disease of NMO in mouse
models.
Indeed, several studies have highlighted the relevance of stem
cells derived astrocytes in disease modeling. Some examples are
mentioned below (Table 5).
CONCLUSION
Astrocytes are fundamentally involved in various neurological
diseases as a consequence of either loss or gain of astrocyte
function, and it is now clear that these disorders arise
from a complex combination of abnormalities in either
neurons, glial cells or immune cells. Recent data suggests
that early stages of neurodegenerative disease, for example,
are associated with loss of synaptic connectivity, imbalances
in neurotransmitter homeostasis, leading to neuronal death
probably through increased excitotoxicity in later stages.
In the end-stage of neurodegeneration, astrocytes become
activated and contribute to neuroinflammatory components
of neurodegeneration. Therefore to understand the principles
of neurodegeneration and its biology, hPSC-derived neuroglia
could serve as a promising tool for creating in vivo-like
cellular models for dementia and neurological disorders
such as ALS, AxD where patient’s neuronal tissue is highly
inaccessible.
Neural precursors derived from hPSCs represent an attractive
tool for the in vitro generation of various neural cell types. In
this present review, we have performed a side-to-side comparison
of existing protocols and evaluated the astrocyte differentiation
based on cellular morphology and gene expression analyses
from the human PSCs. Thus RG-like cells expressing RG
markers BLBP, GLAST, vimentin, and GFAP could serve as
a robust tool for an efficient astroglial generation. We hope
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this review has shed light on the current progress of astrocyte
research.
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